FDA Approved Diabetes Treatment Invokana Causing Major Risks
Invokana has been approved to help those with Type 2 diabetes reduce their risk. This medication is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that works by helping the kidney excrete more glucose into the urine rather than having the glucose be absorbed into the body. As a result, Invokana helps diabetics maintain healthy blood sugar levels. Invokana is currently the only oral treatment for Type 2 diabetes and is a product of Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
Despite the promising benefits of Invokana, there are over 1,000 pending lawsuits against the company claiming severe side effects from the use of Invokana. These side effects include heart attacks, strokes, kidney failure, and amputations as a result of the SGLT2 inhibitor.
The FDA became aware of the serious side effects of Invokana in October 2015, over two and a half years after its initial approval. In June 2016, the FDA increased the warnings for the drug and in May 2017, the FDA mandated that Janssen Pharmaceuticals include a black box warning on all Invokana packaging.
People with Type 2 diabetes often do everything in their power to avoid amputation and serious complications from their lifelong condition. Companies that do not provide adequate warnings for their product and subsequently cause patients severe injuries should be held accountable.
The compassionate attorneys at Whitley Law Firm are here to help you seek compensation for the injuries you sustained and support you throughout the legal process. Do not hesitate to reach out to our attorneys at Whitley Law Firm if you or a loved one have experienced any of the life-changing side effects associated with Invokana.